Status | Study |
Completed |
Study Name: Evaluation of Pediatric Measles Cases in 2019: Single-Center Experience Condition: Measles Date: 2022-11-06 Interventions: Not Provided |
Not yet recruiting |
Study Name: Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella Condition: Rubella Measles Date: 2017-05-09 Interventions: Biological: Measles and Rubella vaccine |
Not yet recruiting |
Study Name: Mobile and Scalable Innovations for Measles Immunization: a Randomized Controlled Trial Condition: Measles Date: 2016-09-08 Interventions: Behavioral: SMS reminder Careg |
Active, not recruiting |
Study Name: MMR and MMRV Vaccines: Effect of Age at First Dose on Safety and Immunogenicity of the Measles Component. Condition: Measles Date: 2016-03-14 Interventions: Biological: MMR vaccine / MMRV vaccine Subcutaneous injection, two doses |
Not yet recruiting |
Study Name: mHealth to Increase Measles Immunization - a Randomized Controlled Trial in Guinea-Bissau Condition: Measles Date: 2016-01-20 Interventions: Other: SMS reminder message Other: Voice c |
Not yet recruiting |
Study Name: Early Waning of Maternal Measles and Meningitis C Antibodies Condition: Measles Date: 2014-08-13 |
Completed |
Study Name: Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella Condition: Rubella Measles Date: 2014-07-16 Interventions: Biological: Double viral (MR) vaccine Measles and Rubella vaccine, as single arm |
Completed |
Study Name: Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age Condition: Measles; Mumps; Rubella Date: 2014-07-03 Interventions: Biological: GSK Biologicals measles, mumps and rubella vaccine live (GSK 209 |
Completed |
Study Name: Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Specified Drug-use Survey of Vaccinees After the Second Vaccination Condition: Measles/Rubella Date: 2014-06-04 Interventions: Drug: Freeze-dried live attenuated measles and rubella combined vaccine (Schwarz FF-8 strain/TO-336 strain) |
Completed |
Study Name: Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Special Drug Use Surveillance of Vaccinees After the First Vaccination Condition: Measles/Rubella Date: 2014-05-28 Interventions: Drug: Freeze-dried live attenuated measles and rubella combined vaccine (Schwarz FF-8 strain/TO-336 strain) |